Northern Trust’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-409,532
Closed -$3.45M 4340
2015
Q4
$3.45M Buy
409,532
+4,154
+1% +$27.8K ﹤0.01% 2704
2015
Q3
$1.69M Buy
405,378
+336,946
+492% +$1.47M ﹤0.01% 3128
2015
Q2
$361K Buy
+68,432
New +$438K ﹤0.01% 3638

Northern Trust's OCAT Position: Q1 2016 in Review

Northern Trust sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 409,532 shares — an estimated $3.45M sold.

Northern Trust first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $3.45M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Northern Trust reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Northern Trust sold 409,532 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $3.45M.
  • Northern Trust first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Northern Trust's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $3.45M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Northern Trust's 13F filing for Q1 2016, filed 13 May 2016.